Monday, April 06, 2026

PBM Formulary Exclusions Are Going Away, Ending "Not Covered" By Your Insurance

›
For years, people with Type 1 diabetes in the United States have been told some version of the same thing at the pharmacy counter: that'...
Thursday, March 19, 2026

Unbranded Humalog Is Cheap on TrumpRx—And GoodRx Enables It.

›
  Back on January 27, 2026, the Office of Inspector General ("OIG") for the U.S. Department of Health and Human Services ("HH...
Tuesday, March 03, 2026

Comment until March 16, 2026 on FTC-Express Scripts Proposed Settlement Agreement

›
Today, I am opining on the recent proposed "settlement" agreement with the Federal Trade Commission (FTC) and Cigna's Evernort...
Friday, February 20, 2026

We Already Have Generic GLP-1s. Why Don't Prices Reflect That? Answer: PBM Pricing Arbitrage.

›
The focus of this blog is the autoimmune form of diabetes known as Type 1 diabetes (T1D), which has exactly one FDA-approved treatment (insu...
Thursday, January 22, 2026

Calling All Hackers: Find a Way to Enable Patients to Have Alarms and Share Dexcom Stelo or Abbott Lingo Readings With Others and You Might Just Have a Business!

›
Back on August 26, 2024, Dexcom, Inc. introduced its first over‑the‑counter (OTC) continuous glucose monitor branded as the Dexcom Stelo (se...
Wednesday, October 08, 2025

From "Out of Stock" to Fulfillment: How Mark Cuban Cost Plus Drug Company's 2023 HealthDyne Deal Improved Drug Distribution

›
Several years ago, I blogged about a PBM-powered coupon-generating app and website operated by WellDyne , which was from one of the smaller ...
Monday, October 06, 2025

After 50 Years with T1D, I Still Have Advocacy Work to Do

›
In July 2026, I'll become eligible for Joslin's Half-Century Medal , awarded to those who have lived with Type 1 diabetes (T1D) for ...
1 comment:
Sunday, September 28, 2025

Dexcom's Management Obscures Receivables, Hides Days Sales Outstanding (DSO), and Spins a Narrative Investors Shouldn't Trust

›
This is certainly a "Business of Diabetes" story. Dexcom Inc., once the undisputed leader in continuous glucose monitoring, now fi...